Concept Medicals vierte IDE-Zulassung für den MagicTouch Sirolimus Coated Balloon wird für die Behandlung von oberflächlichen Oberschenkelarterienerkrankung (Superficial Femoral Artery Disease, SFA) erteilt ...Middle East

TAMPA, Florida, 30. Mai 2023 /PRNewswire/ -- Die US-amerikanische Zulassungsbehörde FDA hat am 24. Mai 2023 eine IDE-Zulassung (Investigational Device Exemption) für den Sirolimus-beschichteten Ballon (SCB) MagicTouch PTA von Concept Medical Inc. zur Behandlung von oberflächlichen...

Hence then, the article about concept medicals vierte ide zulassung fur den magictouch sirolimus coated balloon wird fur die behandlung von oberflachlichen oberschenkelarterienerkrankung superficial femoral artery disease sfa erteilt was published today ( Tuesday 30/05/2023 - 07:41 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Concept Medicals vierte IDE-Zulassung für den MagicTouch Sirolimus Coated Balloon wird für die Behandlung von oberflächlichen Oberschenkelarterienerkrankung (Superficial Femoral Artery Disease, SFA) erteilt )

Also on site :

• Advantech Unveils Next-Generation Edge AI Compute Solutions Powered by Qualcomm Dragonwing IQ-X Series
• From collapse fears to resilience: How Russia reshaped its economy by the end of 2025
• Russian MOD shows map of Ukrainian drone attack on Putin’s residence